Comparison of the calmodulin antagonists compound 48/80 and calmidazolium
- 15 December 1983
- journal article
- research article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 216 (3), 611-616
- https://doi.org/10.1042/bj2160611
Abstract
The 2 presumed calmodulin antagonists, calmidazolium and compound 48/80, were compared for their effects on several calmodulin-dependent and calmodulin-independent enzyme systems. Compound 48/80 and calmidazolium were about equipotent in antagonizing the calmodulin-dependent fraction of brain phosphodiesterase and erythrocyte Ca2+-transporting ATPase. Compound 48/80 combines high potency with high specificity. The basal, calmodulin-independent activity of calmodulin-regulated enzymes was not suppressed. Calmodulin-independent enzyme activities, such as Ca2+-transporting ATPase of sarcoplasmic reticulum, Mg2+-dependent ATPases of different tissues and Na+/K+-transporting ATPase of cardiac sarcolemma, were far less altered or not altered at all, by compound 48/80 as compared with calmidazolium. Antagonism of proteolysis-induced stimulation as opposed to calmodulin-induced activation of erythrocyte Ca2+-transporting ATPase required a 32 times higher concentration of compound 48/80. Compound 48/80 was a superior antagonist to calmidazolium since inhibition of calmodulin-independent events by the other agent occurred at considerably lower concentrations. Compound 48/80 is apparently a much more specific and useful tool for studing the participation of calmodulin in biological processes than the presently used agents.This publication has 27 references indexed in Scilit:
- Specific inhibition of a calcium dependent activation of brain cyclic AMP phosphodiesterase activity by vinblastineCellular and Molecular Life Sciences, 1979
- Ca2+ regulated modulator protein interacting agents: Inhibition of Ca2+Mg2+-ATPase of human erythrocyte ghostBiochemical and Biophysical Research Communications, 1979
- Separation of vesicles of cardiac sarcolemma from vesicles of cardiac sarcoplasmic reticulum. Comparative biochemical analysis of component activities.Journal of Biological Chemistry, 1979
- Modulator binding protein. Bovine brain protein exhibiting the Ca2+-dependent association with the protein modulator of cyclic nucleotide phosphodiesterase.Journal of Biological Chemistry, 1977
- Calcium-dependent cyclic nucleotide phosphodiesterase from brain: Identification of phospholipids as calcium-independent activatorsArchives of Biochemistry and Biophysics, 1976
- Characterization of Cardiac Sarcoplasmic Reticulum ATP‐ADP Phosphate Exchange and Phosphorylation of the Calcium Transport Adenosine TriphosphataseEuropean Journal of Biochemistry, 1976
- MECHANISM BY WHICH PSYCHOTROPIC-DRUGS INHIBIT ADENOSINE CYCLIC 3',5'-MONOPHOSPHATE PHOSPHODIESTERASE OF BRAIN1976
- Sensitive automated methods for phosphate and (Na+ + K+)-ATPaseAnalytical Biochemistry, 1974
- Isolation of sarcoplasmic reticulum by zonal centrifugation and purification of Ca2+-pump and Ca2+-binding proteinsBiochimica et Biophysica Acta (BBA) - Biomembranes, 1973
- The inhibition of the sarcoplasmic calcium pump by prenylamine, reserpine, chlorpromazine and imipramineNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1968